Navigation Links
Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
Date:3/8/2011

is available in 50-unit and 100-unit vials, which Merz believes may allow for more precise billing and reduce wastage.

IMPORTANT SAFETY INFORMATIONWARNING: Distant Spread of Toxin EffectPostmarketing reports indicate that the effects of XEOMIN and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and at lower doses.CONTRAINDICATIONSXEOMIN is contraindicated in patients with a known hypersensitivity to the active substance botulinum toxin type A or to any of the components in the formulation and in the presence of infection at the proposed injection site(s).

WARNINGS AND PRECAUTIONS

  • The potency units of XEOMIN are not interchangeable with other preparations of botulinum toxin products.  Therefore, units of biological activity of XEOMIN cannot be compared to or converted into units of any other botulinum toxin products.
  • Hypersensitivity reactions have been reported with botulinum toxin products (anaphylaxis, serum sickness, urticaria, soft tissue edema, and dyspnea). If serious and/or immediate hypersensitivity reactions occur further injection of
    '/>"/>

  • SOURCE Merz Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/30/2015)... March 30, 2015  BioPharmX Corporation (OTCQB: BPMX), ... of novel drug delivery products to address unmet ... announced the appointment of Stephen Morlock , ... to its board of directors.  Mr. Morlock,s background ... expand its national roll-out of Violet iodine, the ...
    (Date:3/30/2015)... 30, 2015 Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid ... Obama for establishing a National Action Plan with ... threat of antibiotic resistance. We look forward to continuing ...
    (Date:3/30/2015)... 30, 2015 Beta-O2 ... as the company,s new chief executive officer. Dr. ... leading early stage Israeli venture capital firm. He is ... and vascular surgery.        (Logo: http://photos.prnewswire.com/prnh/20140910/705638) ... Sherpa Innoventures is Beta-O2,s newest investor, having participated in ...
    Breaking Medicine Technology:BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3Alere Applauds President's National Action Plan to Combat Antibiotic-Resistant Bacteria 2Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3
    ... Legal-Bay LLC, through its website lawsuitssettlementfunding.com ... to plaintiffs in need of lawsuit cash advances ... an industry leader; however they are striving to set ... company announced that they have ramped up their operations ...
    ... Assured Pharmacy (Pink Sheets: APHYD ), a ... than 3,000 sufferers of chronic pain, is pleased to ... completed an audit of Assured Pharmacy,s consolidated financial statements ... financial statements have been posted on the OTC Markets ...
    Cached Medicine Technology:Legal-Bay LLC Announces Opening of Jones Act Lawsuit Funding Division 2Assured Pharmacy Completes Audit of 2010 Financial Statements 2
    (Date:3/30/2015)... 2015 Textile Exchange, a global nonprofit ... today announced the latest version of its Responsible ... that can be applied to any waterfowl-based supply chain ... to end product. The goal of the RDS is ... and to enable traceability so that products can be ...
    (Date:3/30/2015)... “We are pleased to announce three volunteer pilot ... in Los Angeles,” said Mark Wolper, Chair of Endeavor ... a nationwide call for nominations. , The awards ... Durden with LightHawk and Stephen Purello of Angel Flight ... will receive a $15,000 contribution from the Endeavor Awards ...
    (Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an article ... new treatment options for dealing with stubborn, unwanted fat. Two ... product. The other three technologies use devices to deliver ultrasound ... cold ( CoolSculpting ) to kill fat cells. (see: goo.gl/NmaB4q) ... to permanently remove unwanted fat," says Dr. Simon Ourian, Medical ...
    (Date:3/30/2015)... 2015 Innovaacom, a leading provider of ... announced it is expanding its services into Asia in ... of the world comes at a time when Asia’s ... for better healthcare. A rapidly growing aging population and ... advances in medicine in Asia. “We are excited to ...
    (Date:3/30/2015)... (PRWEB) March 30, 2015 According to ... ), the hernia repair market will continue to dominate ... is occurring primarily due to increasing numbers of ventral ... them. , “The significantly large market share represented ... generally high ASP. We’re seeing a growing use of ...
    Breaking Medicine News(10 mins):Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:2015 Endeavor Awards Recipients Announced 2Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3
    ... The United States,Agency for International Development (USAID) is ... solution that reduces the risk of,diarrhea. Sur,Eau is ... chlorine solution can be added to water immediately ... principally young children and,people living with HIV and ...
    ... April 25 Torchmark,Corporation (NYSE: TMK ) announced ... of $.14 per share on all of the outstanding ... the close of business of the,Company,s transfer agent on ... 1, 2008., Torchmark Corporation is a holding company ...
    ... April 25 AMDL, Inc. (Amex:,ADL), an international ... and diagnostic products in China, announced,today that a ... AMDL has been posted,by analyst Lauren Rudd at ... price of $23 and a Buy Recommendation., ...
    ... G.,Rendell said national "Cover the Uninsured Week" is the ... Basic Care (PA ABC), which,passed the House of Representatives ... care to hundreds of thousands of uninsured,Pennsylvanians., "Cover ... "Every day we hear from Pennsylvanians who are ...
    ... TV Game Show Host Spark Controversy, LOS ANGELES, ... television game show "The Price Is Right," recently spoke ... group formed to,support responsible dog ownership. The group has ... went into effect this month in Los,Angeles County (isn,t ...
    ... eye surgery, but complaints show it may not be for ... Tiger Woods lauds vision-correcting LASIK surgery as "life changing." NASA ... military says it has been performed on 112,500 military personnel, ... and complications of this elective surgery being lost in this ...
    Cached Medicine News:Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:The Rudd Report, Dated April 18, 2008, Updates AMDL's Recent Achievements 2Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 2Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 3Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 4Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 5Health News:Governor Rendell Says 'Cover the Uninsured Week' is Perfect Time for Action on Program to Provide Access to Health Care for Uninsured 6Health News:Bob Barker's 'Right' to Free Speech Comes with a 'Price' 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 2Health News:FDA Examines 'Quality of Life' for LASIK Patients 3
    ... Anatomical Malar I Implants - Providing the ... follows the contour of the zygoma while ... Anatomical Malar II Implants - The ... surgeon with another augumentation option that adds ...
    Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
    ... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
    ... Thermos IEC CL31 Multispeed Series ... in a quiet, compact, 1.2 liter ... of rotors and accessories and high-speed ... offers virtually everything you need to ...
    Medicine Products: